Other Issues

Select an Issue

Browse Other Issues Content

three quarter view of U.S. capitol building from below

Press Releases and Statements

CHPA Applauds Senate Introduction of DXM Abuse Prevention Act

CHPA is pleased to lend its strong support for the DXM Abuse Prevention Act (S. 2994), introduced into the U.S. Senate by Senators Bob Casey Jr. (D-PA) and Lisa Murkowski (R-AK).

May 16, 2016

dandelion, capsules, and brown bottle

Submission

Comments to FDA: Use of the Term "natural" in the Labeling of Human Food

CHPA appreciates the opportunity to provide information relevant to use of the term “natural” in food labeling, and believes that a formal definition will help to reduce consumer confusion and provide clarity to manufacturers and marketers making claims relying upon such a definition.

May 10, 2016

Image of pseudoephedrine label

Press Releases and Statements

CHPA Applauds Georgia's Adoption of Real-Time, Stop Sale Technology to Prevent Illegal Sales of Pseudoephedrine

CHPA applauds the state of Georgia for becoming the thirty-third state to adopt the real-time, stop-sale technology called the National Precursor Log Exchange (NPLEx).

Apr 28, 2016

Black teenager on their smartphone

Press Releases and Statements

House Subcommittee Marks Up Legislation to Prevent Teen Over-the-Counter Cough Medicine Abuse

CHPA, which represents leading manufacturers of OTC cough medicines, strongly supports this legislation and is joined many by substance abuse prevention organizations such as the Community Anti-Drug Coalitions of America and the Partnership for Drug-Free Kids.

Apr 20, 2016

florida capitol building with trees and clouds

Press Releases and Statements

CHPA Applauds Florida Lawmakers for Age-18 Sales Law on Cough Medicine

CHPA released the following statement today in support of a Florida law prohibiting the sale of OTC medicines containing the cough suppressant dextromethorphan (DXM) to minors.

Apr 1, 2016

Orange CHPA logo on dark blue background

Submission

Comments to FDA: Fixed-Combination and Co-Packaged Drugs

In general, CHPA supports FDA's intent to harmonize the requirements for Rx and OTC products and make them consistent with long-standing Agency policy.

Mar 22, 2016

Pink and orange gummy vitamins

Submission

Comments to NIH: Dietary Supplement Label Database

CHPA appreciates the opportunity to provide information on features to add and potential functionality improvements to make the Dietary Supplement Label Database a more useful tool for regulators, consumers, and other users of the database.

Dec 31, 2015

Female Scientist wearing goggles

Submission

EPA Proposed Management Standards for Hazardous Waste Pharmaceuticals

CHPA supports EPA's efforts to streamline regulations under RCRA. CHPA has two central comments on the proposal.

Dec 23, 2015

lake and mountains

Press Releases and Statements

CHPA Statement on Passage of Microbead-Free Waters Act of 2015

CHPA commends the U.S. House of Representatives for swift passage of the Microbead-Free Waters Act of 2015 (H.R. 1321).

Dec 7, 2015

woman in green shirt measuring liquid medicine

Submission

Comments to USP: Dosage Forms Expert Committee Proposed Revisions

CHPA supports improving the compendial test methods and establishing product standards for the variety of dosage forms, which can provide an additional measure of safety for OTC products.

Nov 30, 2015

Filter Results